These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16396984)

  • 61. FFA-induced hepatic insulin resistance in vivo is mediated by PKCδ, NADPH oxidase, and oxidative stress.
    Pereira S; Park E; Mori Y; Haber CA; Han P; Uchida T; Stavar L; Oprescu AI; Koulajian K; Ivovic A; Yu Z; Li D; Bowman TA; Dewald J; El-Benna J; Brindley DN; Gutierrez-Juarez R; Lam TK; Najjar SM; McKay RA; Bhanot S; Fantus IG; Giacca A
    Am J Physiol Endocrinol Metab; 2014 Jul; 307(1):E34-46. PubMed ID: 24824652
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of 3-hydroxybutyrate and free fatty acids on muscle protein kinetics and signaling during LPS-induced inflammation in humans: anticatabolic impact of ketone bodies.
    Thomsen HH; Rittig N; Johannsen M; Møller AB; Jørgensen JO; Jessen N; Møller N
    Am J Clin Nutr; 2018 Oct; 108(4):857-867. PubMed ID: 30239561
    [TBL] [Abstract][Full Text] [Related]  

  • 63. L-carnitine infusion does not alleviate lipid-induced insulin resistance and metabolic inflexibility.
    Bruls YMH; Op den Kamp YJM; Phielix E; Lindeboom L; Havekes B; Schaart G; Moonen-Kornips E; Wildberger JE; Hesselink MKC; Schrauwen P; Schrauwen-Hinderling VB
    PLoS One; 2020; 15(9):e0239506. PubMed ID: 32976523
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lipids activate skeletal muscle mitochondrial fission and quality control networks to induce insulin resistance in humans.
    Axelrod CL; Fealy CE; Erickson ML; Davuluri G; Fujioka H; Dantas WS; Huang E; Pergola K; Mey JT; King WT; Mulya A; Hsia D; Burguera B; Tandler B; Hoppel CL; Kirwan JP
    Metabolism; 2021 Aug; 121():154803. PubMed ID: 34090870
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Excess Accumulation of Lipid Impairs Insulin Sensitivity in Skeletal Muscle.
    Park SS; Seo YK
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32178449
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice.
    Sleeman MW; Garcia K; Liu R; Murray JD; Malinova L; Moncrieffe M; Yancopoulos GD; Wiegand SJ
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14297-302. PubMed ID: 14610276
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ciliary neurotrophic factor analogue aggravates CCl
    Cui MX; Jiang JF; Min GN; Han W; Wu YJ
    Can J Physiol Pharmacol; 2017 May; 95(5):620-623. PubMed ID: 28177690
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lipid-induced insulin resistance is not mediated by impaired transcapillary transport of insulin and glucose in humans.
    Szendroedi J; Frossard M; Klein N; Bieglmayer C; Wagner O; Pacini G; Decker J; Nowotny P; Müller M; Roden M
    Diabetes; 2012 Dec; 61(12):3176-80. PubMed ID: 22891212
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Insulin resistance in non-obese subjects is associated with activation of the JNK pathway and impaired insulin signaling in skeletal muscle.
    Masharani UB; Maddux BA; Li X; Sakkas GK; Mulligan K; Schambelan M; Goldfine ID; Youngren JF
    PLoS One; 2011 May; 6(5):e19878. PubMed ID: 21589939
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Protein kinase C and lipid-induced insulin resistance in skeletal muscle.
    Schmitz-Peiffer C
    Ann N Y Acad Sci; 2002 Jun; 967():146-57. PubMed ID: 12079844
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacological TLR4 Inhibition Protects against Acute and Chronic Fat-Induced Insulin Resistance in Rats.
    Zhang N; Liang H; Farese RV; Li J; Musi N; Hussey SE
    PLoS One; 2015; 10(7):e0132575. PubMed ID: 26196892
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Overexpression of muscle lipoprotein lipase and insulin sensitivity.
    Pulawa LK; Eckel RH
    Curr Opin Clin Nutr Metab Care; 2002 Sep; 5(5):569-74. PubMed ID: 12172482
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Experimental hyperlipidemia dramatically reduces access of insulin to canine skeletal muscle.
    Chiu JD; Kolka CM; Richey JM; Harrison LN; Zuniga E; Kirkman EL; Bergman RN
    Obesity (Silver Spring); 2009 Aug; 17(8):1486-92. PubMed ID: 19521354
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lipid-induced insulin resistance in the liver: role of exercise.
    Katsanos CS
    Sports Med; 2004; 34(14):955-65. PubMed ID: 15571427
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ciliary neurotrophic factor upregulates follistatin and Pak1, causes overexpression of muscle differentiation related genes and downregulation of established atrophy mediators in skeletal muscle.
    Tsompanidis A; Vafiadaki E; Blüher S; Kalozoumi G; Sanoudou D; Mantzoros CS
    Metabolism; 2016 Jun; 65(6):915-25. PubMed ID: 27173470
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of Sustained Hyperglycemia on Skeletal Muscle Lipids in Healthy Subjects.
    Shannon CE; Merovci A; Fourcaudot M; Tripathy D; Abdul-Ghani M; Wang H; Han X; Norton L; DeFronzo RA
    J Clin Endocrinol Metab; 2022 Jul; 107(8):e3177-e3185. PubMed ID: 35552423
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ciliary neurotrophic factor overexpression in neural progenitor cells (ST14A) increases proliferation, metabolic activity, and resistance to stress during differentiation.
    Weinelt S; Peters S; Bauer P; Mix E; Haas SJ; Dittmann A; Petrov S; Wree A; Cattaneo E; Knoblich R; Strauss U; Rolfs A
    J Neurosci Res; 2003 Jan; 71(2):228-36. PubMed ID: 12503085
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lipid-induced insulin resistance is associated with an impaired skeletal muscle protein synthetic response to amino acid ingestion in healthy young men.
    Stephens FB; Chee C; Wall BT; Murton AJ; Shannon CE; van Loon LJ; Tsintzas K
    Diabetes; 2015 May; 64(5):1615-20. PubMed ID: 25524913
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes.
    Yung JHM; Giacca A
    Cells; 2020 Mar; 9(3):. PubMed ID: 32183037
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CNTF: a target therapeutic for obesity-related metabolic disease?
    Matthews VB; Febbraio MA
    J Mol Med (Berl); 2008 Apr; 86(4):353-61. PubMed ID: 18210031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.